We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
In cooperation with Association of Corporate Counsel
  Request new password

Search results

Order by most recent / most popular / relevance

Results: 1-10 of 1,420

UCSF, CSPI tackle science of sweeteners

  • Shook Hardy & Bacon LLP
  • -
  • USA
  • -
  • November 14 2014

Researchers with the University of California, San Francisco (UCSF), and two other universities have launched a campaign targeting added sugar

APHIS rules GE alfalfa not a plant pest risk

  • Shook Hardy & Bacon LLP
  • -
  • USA
  • -
  • November 14 2014

The U.S. Department of Agriculture's Animal and Plant Health Inspection Service (APHIS) has determined that KK179 alfalfa, a genetically engineered

EWG advises consumers to avoid certain food additives in updated Guide

  • Shook Hardy & Bacon LLP
  • -
  • USA
  • -
  • November 14 2014

Consumer advocacy watchdog Environmental Working Group (EWG) has issued a new iteration of its "Dirty Dozen Guide to Food Additives." Reportedly

USDA approves GE potato for market

  • Shook Hardy & Bacon LLP
  • -
  • USA
  • -
  • November 14 2014

The U.S. Department of Agriculture's (USDA's) Animal and Plant Health Inspection Service (APHIS) has approved for commercial planting a new variety

Australian public health coalition advocates national tax on SSBs

  • Shook Hardy & Bacon LLP
  • -
  • Australia, USA
  • -
  • November 14 2014

Calling Berkeley, California, voters' recent passage of a 1-cent-per-ounce tax on sugar-sweetened beverages (SSBs) a "victory for the health of

New York legislator renews call for SSB warning labels

  • Shook Hardy & Bacon LLP
  • -
  • USA
  • -
  • November 14 2014

According to press reports, New York Assemblyman Karim Camara (D-Brooklyn) announced this week that he intends to propose legislation requiring

News bytes

  • Shook Hardy & Bacon LLP
  • -
  • USA
  • -
  • November 13 2014

The U.S. Food and Drug Administration (FDA) makes available Guidance for Industry and staff titled "Molecular Diagnostic Instruments with Combined

RAND Corp. predicts $44.2 billion in savings with biosimilars

  • Shook Hardy & Bacon LLP
  • -
  • USA
  • -
  • November 13 2014

The Rand Corp. has issued a perspective titled "The Cost Savings Potential of Biosimilar Drugs in the United States." It predicts that "biosimilars

Ranbaxy loses FDA approval for two generics

  • Shook Hardy & Bacon LLP
  • -
  • India, USA
  • -
  • November 13 2014

According to a statement that Ranbaxy Laboratories Ltd. provided to the Bombay Stock Exchange Website, the U.S. Food and Drug Administration (FDA

CNS drug approvals take longer, are rejected more often

  • Shook Hardy & Bacon LLP
  • -
  • USA
  • -
  • November 13 2014

A new Tufts Center for the Study of Drug Development report reveals that drugs to treat central nervous system (CNS) disorders take longer to develop